(14C)Aminopyrine breath test in chronic liver disease: preliminary diagnostic implications
The (14C)aminopyrine breath test (APBT) score, an estimate of hepatic mixed-oxidase function, was evaluated in 21 consecutive patients wih active nonalcoholic chronic liver diseases. Ten had primary biliary cirrhosis (PBC) and 11 had chronic active hepatitis (CAH). The APBT score was normal or elevated in patients with PBC (P less than 0.001), and lower than normal in CAH patients (P less than 0.01); 10.5 +/- 1.6 and 3.5 +/- 1.86, respectively, vs control 7.65 +/- 1.15 (mean +/- SD). The 11 patients with CAH included two middle-aged women who displayed ambiguous severe intrahepatic cholestasis. There was no overlap between the APBT scores of the 10 PBC and 11 CAH patients. These initial data suggest that the APBT may be helpful in the differentiation of PBC and CAH, including misleading cholestatic forms of CAH.
- Research Organization:
- Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
- OSTI ID:
- 5477991
- Journal Information:
- Dig. Dis. Sci.; (United States), Journal Name: Dig. Dis. Sci.; (United States) Vol. 26:12; ISSN DDSCD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cholestatic syndromes in infancy and childhood
Breath /sup 14/CO2 after intravenous administration of (/sup 14/C)aminopyrine in liver diseases